Pacific Biosciences Of California Current Ratio 2010-2024 | PACB
Pacific Biosciences Of California current ratio from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Pacific Biosciences Of California Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-06-30 | $0.63B | $0.08B | 8.01 |
| 2024-03-31 | $0.68B | $0.07B | 9.28 |
| 2023-12-31 | $0.74B | $0.10B | 7.81 |
| 2023-09-30 | $0.88B | $0.18B | 4.80 |
| 2023-06-30 | $0.94B | $0.27B | 3.45 |
| 2023-03-31 | $0.98B | $0.27B | 3.69 |
| 2022-12-31 | $0.85B | $0.26B | 3.24 |
| 2022-09-30 | $0.91B | $0.08B | 11.19 |
| 2022-06-30 | $0.97B | $0.08B | 11.50 |
| 2022-03-31 | $1.03B | $0.06B | 16.87 |
| 2021-12-31 | $1.10B | $0.07B | 15.36 |
| 2021-09-30 | $1.13B | $0.06B | 20.32 |
| 2021-06-30 | $1.19B | $0.05B | 26.17 |
| 2021-03-31 | $1.20B | $0.03B | 35.45 |
| 2020-12-31 | $0.36B | $0.04B | 9.24 |
| 2020-09-30 | $0.24B | $0.13B | 1.84 |
| 2020-06-30 | $0.15B | $0.13B | 1.15 |
| 2020-03-31 | $0.17B | $0.13B | 1.29 |
| 2019-12-31 | $0.08B | $0.05B | 1.65 |
| 2019-09-30 | $0.08B | $0.05B | 1.52 |
| 2019-06-30 | $0.10B | $0.05B | 2.00 |
| 2019-03-31 | $0.11B | $0.05B | 2.50 |
| 2018-12-31 | $0.13B | $0.03B | 4.90 |
| 2018-09-30 | $0.14B | $0.02B | 6.65 |
| 2018-06-30 | $0.10B | $0.02B | 4.33 |
| 2018-03-31 | $0.12B | $0.03B | 4.64 |
| 2017-12-31 | $0.10B | $0.03B | 3.55 |
| 2017-09-30 | $0.11B | $0.03B | 3.75 |
| 2017-06-30 | $0.13B | $0.04B | 3.72 |
| 2017-03-31 | $0.09B | $0.04B | 2.49 |
| 2016-12-31 | $0.11B | $0.03B | 3.23 |
| 2016-09-30 | $0.12B | $0.03B | 3.81 |
| 2016-06-30 | $0.14B | $0.03B | 4.08 |
| 2016-03-31 | $0.12B | $0.03B | 3.72 |
| 2015-12-31 | $0.11B | $0.04B | 2.90 |
| 2015-09-30 | $0.09B | $0.04B | 2.22 |
| 2015-06-30 | $0.09B | $0.04B | 2.31 |
| 2015-03-31 | $0.10B | $0.04B | 2.59 |
| 2014-12-31 | $0.12B | $0.03B | 3.74 |
| 2014-09-30 | $0.11B | $0.03B | 3.92 |
| 2014-06-30 | $0.12B | $0.03B | 4.29 |
| 2014-03-31 | $0.13B | $0.02B | 5.87 |
| 2013-12-31 | $0.13B | $0.02B | 5.61 |
| 2013-09-30 | $0.14B | $0.02B | 6.31 |
| 2013-06-30 | $0.12B | $0.02B | 8.09 |
| 2013-03-31 | $0.13B | $0.01B | 9.31 |
| 2012-12-31 | $0.12B | $0.02B | 7.80 |
| 2012-09-30 | $0.13B | $0.01B | 9.71 |
| 2012-06-30 | $0.15B | $0.02B | 10.23 |
| 2012-03-31 | $0.18B | $0.02B | 8.93 |
| 2011-12-31 | $0.20B | $0.02B | 10.30 |
| 2011-09-30 | $0.22B | $0.02B | 10.42 |
| 2011-06-30 | $0.25B | $0.02B | 11.40 |
| 2011-03-31 | $0.26B | $0.02B | 10.95 |
| 2010-12-31 | $0.29B | $0.02B | 14.07 |
| 2010-09-30 | $0.12B | $0.02B | 5.12 |
| 2010-06-30 | $0.00B | 0.00 | |
| 2010-03-31 | $0.00B | 0.00 | |
| 2009-12-31 | $0.00B | 0.00 | |
| 2009-09-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.510B | $0.201B |
| Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $233.204B | 27.95 |
| Intuitive Surgical (ISRG) | United States | $171.750B | 97.25 |
| Alcon (ALC) | Switzerland | $47.924B | 33.74 |
| IQVIA Holdings (IQV) | United States | $43.748B | 24.79 |
| IDEXX Laboratories (IDXX) | United States | $42.163B | 50.72 |
| Edwards Lifesciences (EW) | United States | $40.499B | 25.96 |
| DexCom (DXCM) | United States | $27.626B | 39.39 |
| STERIS (STE) | Ireland | $23.834B | 27.81 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.222B | 0.00 |
| Waters (WAT) | United States | $19.528B | 29.11 |
| Hologic (HOLX) | United States | $19.046B | 20.71 |
| Sysmex ADR (SSMXY) | Japan | $12.644B | 39.65 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.253B | 13.74 |
| Teleflex (TFX) | United States | $11.376B | 17.69 |
| Globus Medical (GMED) | United States | $9.389B | 26.26 |
| Penumbra (PEN) | United States | $7.266B | 75.43 |
| Glaukos (GKOS) | United States | $6.681B | 0.00 |
| Masimo (MASI) | United States | $6.118B | 32.77 |
| TransMedics (TMDX) | United States | $5.207B | 222.97 |
| Integer Holdings (ITGR) | United States | $4.229B | 24.73 |
| PROCEPT BioRobotics (PRCT) | United States | $4.145B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.819B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.769B | 16.24 |
| Veracyte (VCYT) | United States | $2.636B | 163.43 |
| Inari Medical (NARI) | United States | $2.570B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.537B | 20.67 |
| Nihon Kohden (NHNKY) | Japan | $2.489B | 15.49 |
| RxSight (RXST) | United States | $2.076B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.331B | 6.06 |
| Pulse Biosciences (PLSE) | United States | $1.246B | 0.00 |
| OPKO Health (OPK) | United States | $1.158B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.110B | 19.80 |
| Artivion (AORT) | United States | $1.057B | 97.00 |
| Alphatec Holdings (ATEC) | United States | $0.836B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.753B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.664B | 16.78 |
| SiBone (SIBN) | United States | $0.654B | 0.00 |
| AxoGen (AXGN) | United States | $0.644B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.619B | 0.00 |
| IRadimed (IRMD) | United States | $0.616B | 33.31 |
| Paragon 28 (FNA) | United States | $0.580B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.344B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.335B | 10.22 |
| ClearPoint Neuro (CLPT) | United States | $0.329B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.324B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.308B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.261B | 0.00 |
| Inogen (INGN) | United States | $0.257B | 0.00 |
| Nevro (NVRO) | United States | $0.218B | 0.00 |
| NeuroPace (NPCE) | United States | $0.203B | 0.00 |
| Accuray (ARAY) | United States | $0.189B | 0.00 |
| CVRx (CVRX) | United States | $0.185B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.182B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.178B | 12.47 |
| Alpha Tau Medical (DRTS) | Israel | $0.161B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.141B | 0.00 |
| 908 Devices (MASS) | United States | $0.127B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.117B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.115B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.102B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.098B | 14.61 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.071B | 0.00 |
| InspireMD (NSPR) | Israel | $0.064B | 0.00 |
| Envoy Medical (COCH) | United States | $0.063B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.061B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.060B | 0.00 |
| LENSAR (LNSR) | United States | $0.049B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.039B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.037B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.036B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.035B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Neuronetics (STIM) | United States | $0.029B | 0.00 |
| Lifeward (LFWD) | United States | $0.028B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.023B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Spectral AI (MDAI) | United States | $0.021B | 0.00 |
| PAVmed (PAVM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.010B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |